Literature DB >> 8649587

Bromocriptine and postpartum cerebral angiopathy: a causal relationship?

M Comabella1, J Alvarez-Sabin, A Rovira, A Codina.   

Abstract

We describe a postpartum 30-year-old woman who developed headaches, hypertension, and speech disturbances after bromocriptine treatment to suppress lactation. Brain MRI revealed intraparenchymal hematomas, and an angiographic study showed multiple arterial segmental narrowings compatible with postpartum cerebral angiopathy. We also comment on other cases of postpartum cerebral angiopathy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8649587     DOI: 10.1212/wnl.46.6.1754

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  6 in total

1.  Benign cerebral angiopathy; postpartum cerebral angiopathy: characteristics and treatment.

Authors:  Sofia Calado; Miguel Viana-Baptista
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-05

2.  Delayed ischemic stroke associated with bromocriptine-induced reversible cerebral vasoconstriction syndrome.

Authors:  Young Seo Kim; Wonki Baek; Juhan Kim; Hyun Young Kim; Young-Jun Lee
Journal:  Neurol Sci       Date:  2012-03-15       Impact factor: 3.307

3.  Call-Fleming syndrome associated with subarachnoid haemorrhage: three new cases.

Authors:  R R Moustafa; C M C Allen; J-C Baron
Journal:  BMJ Case Rep       Date:  2009-02-02

Review 4.  Reversible Cerebral Vasoconstriction Syndrome, Part 1: Epidemiology, Pathogenesis, and Clinical Course.

Authors:  T R Miller; R Shivashankar; M Mossa-Basha; D Gandhi
Journal:  AJNR Am J Neuroradiol       Date:  2015-01-15       Impact factor: 3.825

5.  Reversible cerebral vasoconstriction syndrome associated with subarachnoid hemorrhage.

Authors:  Brian L Edlow; Scott E Kasner; Robert W Hurst; John B Weigele; Joshua M Levine
Journal:  Neurocrit Care       Date:  2007       Impact factor: 3.210

Review 6.  Secondary hypertension: interfering substances.

Authors:  Ehud Grossman; Franz H Messerli
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-07       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.